1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with luteolin in 2 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (luteolin) | Trials (luteolin) | Recent Studies (post-2010) (luteolin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 2,402 | 15 | 1,648 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HW; Kudo, I; Samejima, Y; Son, KH; Yanoshita, R | 1 |
Antonopoulou, S; Demopoulos, C; Theoharides, TC | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and luteolin
Article | Year |
---|---|
COVID-19, microthromboses, inflammation, and platelet activating factor.
Topics: Antiviral Agents; Blood Platelets; COVID-19; Cyproheptadine; Disseminated Intravascular Coagulation; Gene Expression Regulation; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Lung; Luteolin; Mast Cells; Platelet Activating Factor; Pulmonary Embolism; Quercetin; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and luteolin
Article | Year |
---|---|
Inhibition of lysoPAF acetyltransferase activity by flavonoids.
Topics: Acetyltransferases; Animals; Cell-Free System; Choline O-Acetyltransferase; Flavonoids; Luteolin; Mast-Cell Sarcoma; Platelet Activating Factor; Rats; Tumor Cells, Cultured | 1996 |